No connection

Search Results

EHC vs UNH

EHC
Encompass Health Corporation
BULLISH
Price
$101.98
Market Cap
$10.14B
Sector
Healthcare
AI Confidence
85%
UNH
UnitedHealth Group Incorporated
NEUTRAL
Price
$323.48
Market Cap
$293.61B
Sector
Healthcare
AI Confidence
85%

Valuation

P/E Ratio
EHC
18.37
UNH
24.43
Forward P/E
EHC
15.74
UNH
16.08
P/B Ratio
EHC
4.18
UNH
3.11
P/S Ratio
EHC
1.71
UNH
0.66
EV/EBITDA
EHC
9.86
UNH
16.47

Profitability

Gross Margin
EHC
43.21%
UNH
18.53%
Operating Margin
EHC
18.35%
UNH
0.34%
Profit Margin
EHC
9.54%
UNH
2.69%
ROE
EHC
24.82%
UNH
12.54%
ROA
EHC
9.66%
UNH
3.9%

Growth

Revenue Growth
EHC
9.9%
UNH
12.3%
Earnings Growth
EHC
21.2%
UNH
-99.9%

Financial Health

Debt/Equity
EHC
0.83
UNH
0.82
Current Ratio
EHC
1.08
UNH
0.79
Quick Ratio
EHC
0.83
UNH
0.7

Dividends

Dividend Yield
EHC
0.75%
UNH
2.73%
Payout Ratio
EHC
12.97%
UNH
65.99%

AI Verdict

EHC BULLISH

EHC presents a stable financial profile with a Piotroski F-Score of 4/9 and a significant valuation gap between its defensive Graham Number ($55.18) and growth-based Intrinsic Value ($163.72). The company exhibits exceptional operational efficiency with an ROE of 24.82% and a highly attractive PEG ratio of 0.41, suggesting the stock is undervalued relative to its earnings growth. While insider sentiment is bearish and technical trends are currently weak, the long-term fundamental trajectory is supported by a 25-quarter track record of consistent earnings beats. The current price of $101.98 represents a reasonable entry point given the analyst target of $142.73.

Strengths
Exceptional earnings track record with consistent beats over 25 quarters
Very low PEG ratio (0.41) indicating strong growth at a reasonable price
High Return on Equity (24.82%) demonstrating efficient capital use
Risks
Bearish insider activity with significant selling by the CEO and other officers
Weak technical trend (0/100) indicating short-term price momentum is negative
Tight liquidity with a current ratio of 1.08
UNH NEUTRAL

UnitedHealth Group presents a conflicted profile with a stable but mediocre Piotroski F-Score of 4/9 and a significant disconnect between current price ($323.48) and defensive fair value (Graham Number: $175.91). While revenue growth remains robust at 12.3%, the company has suffered a catastrophic collapse in YoY earnings growth (-99.9%), suggesting severe short-term headwinds or one-time accounting shocks. Technical trends are currently bearish (0/100), though a recent one-month bounce and a favorable Forward P/E of 16.08 indicate analyst expectations of a recovery. The stock is currently trading at a significant premium to its intrinsic value, relying heavily on its market dominance and future earnings normalization.

Strengths
Strong consistent revenue growth (12.3% YoY)
Manageable Debt/Equity ratio of 0.82
Attractive Forward P/E (16.08) compared to current P/E (24.43)
Risks
Extreme earnings volatility (YoY Earnings Growth -99.9%)
Poor liquidity indicated by a Current Ratio of 0.79
Extremely thin operating margins (0.34%)

Compare Another Pair

EHC vs UNH: Head-to-Head Comparison

This page compares Encompass Health Corporation (EHC) and UnitedHealth Group Incorporated (UNH) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.

Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.

Home
Terminal
AI Chat
Markets
Profile